Biomarker Use in Colorectal Cancer Therapy

被引：29
|
作者：
Kelley, Robin K. [1 ]
Wang, Grace [2 ]
Venook, Alan P.
机构：
[1] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, Dept Med, San Francisco, CA 94115 USA
[2] UCSF, Ctr Translat & Policy Res Personalized Med, San Francisco, CA USA
来源：
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK | 2011年 / 9卷 / 11期
关键词：
Colon cancer; colorectal cancer; biomarker; KRAS; BRAF; microsatellite instability; mismatch repair; REVISED BETHESDA GUIDELINES; DEFECTIVE MISMATCH REPAIR; CIRCULATING TUMOR-CELLS; MICROSATELLITE-INSTABILITY; ADJUVANT CHEMOTHERAPY; COLON-CANCER; LYNCH-SYNDROME; PREDICTIVE BIOMARKERS; MOLECULAR PREDICTORS; THYMIDYLATE SYNTHASE;
D O I：
10.6004/jnccn.2011.0105
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Biomarkers reflective of the molecular and genetic heterogeneity in colorectal cancers now guide certain aspects of clinical management and offer great potential for enrichment, stratification, and identification of novel therapeutic targets in drug development. Using case-based examples, this article reviews biomarkers that have an established role in the clinical management of colorectal cancer: mismatch repair protein testing and KRAS and BRAF mutational analysis. A selection of biomarkers undergoing validation for future clinical application is presented, and the dynamic and challenging interface between biomarkers in research and clinical practice is discussed. (JNCCN 2011;9:1293-1303)
引用
收藏
页码：1293 / 1302
页数：10
相关论文
共 50 条
  • [21] GUCY2C as a biomarker to target precision therapies for patients with colorectal cancer
    Lisby, Amanda N.
    Flickinger, John C., Jr.
    Bashir, Babar
    Weindorfer, Megan
    Shelukar, Sanjna
    Crutcher, Madison
    Snook, Adam E.
    Waldman, Scott A.
    EXPERT REVIEW OF PRECISION MEDICINE AND DRUG DEVELOPMENT, 2021, 6 (02): : 117 - 129
  • [22] Microsatellite instability in stage II colorectal cancer: An Indian perspective
    Dubey, A. P.
    Vishwanath, S.
    Nikhil, P.
    Rathore, A.
    Pathak, A.
    INDIAN JOURNAL OF CANCER, 2016, 53 (04) : 513 - 517
  • [23] Toward a personalized treatment of colorectal cancer: prognostic and predictive factors
    Lievre, A.
    ONCOLOGIE, 2010, 12 (10) : 584 - 592
  • [24] Microsatellite instability in colorectal cancer
    Iacopetta, Barry
    Grieu, Fabienne
    Amanuel, Benhur
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2010, 6 (04) : 260 - 269
  • [25] Molecular Diagnostics of Colorectal Cancer
    Bedeir, Ahmed
    Krasinskas, Alyssa M.
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2011, 135 (05) : 578 - 587
  • [26] Molecular pathways in colorectal cancer
    Al-Sohaily, Sam
    Biankin, Andrew
    Leong, Rupert
    Kohonen-Corish, Maija
    Warusavitarne, Janindra
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2012, 27 (09) : 1423 - 1431
  • [27] Do lifestyle factors influence colorectal cancer risk in Lynch syndrome?
    van Duijnhoven, Franzel J. B.
    Botma, Akke
    Winkels, Renate
    Nagengast, Fokko M.
    Vasen, Hans F. A.
    Kampman, Ellen
    FAMILIAL CANCER, 2013, 12 (02) : 285 - 293
  • [28] Combination of microsatellite instability and BRAF mutation status for subtyping colorectal cancer
    Seppala, T. T.
    Bohm, J. P.
    Friman, M.
    Lahtinen, L.
    Vayrynen, V. M. J.
    Liipo, T. K. E.
    Ristimaki, A. P.
    Kairaluoma, M. V. J.
    Kellokumpu, I. H.
    Kuopio, T. H. I.
    Mecklin, J-P
    BRITISH JOURNAL OF CANCER, 2015, 112 (12) : 1966 - 1975
  • [29] Individualized therapy for metastatic colorectal cancer
    Silvestri, A.
    Pin, E.
    Huijbers, A.
    Pellicani, R.
    Parasido, E. M.
    Pierobon, M.
    Petricoin, E.
    Liotta, L.
    Belluco, C.
    JOURNAL OF INTERNAL MEDICINE, 2013, 274 (01) : 1 - 24
  • [30] Molecular pathology of colorectal cancer
    Neumann, J. H. L.
    Jung, A.
    Kirchner, T.
    PATHOLOGE, 2015, 36 (02): : 137 - 144
12345